{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T19:33:56Z","timestamp":1649100836586},"reference-count":28,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,1,1]]},"DOI":"10.1210\/jcem.83.1.4448","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T12:02:30Z","timestamp":1389182550000},"page":"6-13","source":"Crossref","is-referenced-by-count":0,"title":["Reproductive Endocrine and Endometrial Effects of Raloxifene Hydrochloride, a Selective Estrogen Receptor Modulator, in Women with Regular Menstrual Cycles1"],"prefix":"10.1210","volume":"83","author":[{"given":"Valerie L.","family":"Baker","sequence":"first","affiliation":[{"name":"Reproductive Endocrinology Center, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California (V.L.B., J.S., R.B.J.), San Francisco, California 94143;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Draper","sequence":"additional","affiliation":[{"name":"Eli Lilly Co. (M.D., S.P., S.A.), Indianapolis, Indiana 46285;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Paul","sequence":"additional","affiliation":[{"name":"Eli Lilly Co. (M.D., S.P., S.A.), Indianapolis, Indiana 46285;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandy","family":"Allerheiligen","sequence":"additional","affiliation":[{"name":"Eli Lilly Co. (M.D., S.P., S.A.), Indianapolis, Indiana 46285;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Glant","sequence":"additional","affiliation":[{"name":"Diagnostic Cytology Laboratories (M.G.), Indianapolis, Indiana 46268"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Shifren","sequence":"additional","affiliation":[{"name":"Reproductive Endocrinology Center, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California (V.L.B., J.S., R.B.J.), San Francisco, California 94143;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B.","family":"Jaffe","sequence":"additional","affiliation":[{"name":"Reproductive Endocrinology Center, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California (V.L.B., J.S., R.B.J.), San Francisco, California 94143;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2019041117204379700_R1","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1126\/science.273.5279.1222","article-title":"Identification of an estrogen response element activated by metabolites of 17\u03b2-estradiol and raloxifene.","volume":"273","author":"Yang","year":"1996","journal-title":"Science"},{"key":"2019041117204379700_R2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1172\/JCI116985","article-title":"Raloxifene (LY139481) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.","volume":"93","author":"Black","year":"1994","journal-title":"J Clin Invest"},{"key":"2019041117204379700_R3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jbmr.5650110615","article-title":"A controlled trial of raloxifene (LY 139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women.","volume":"11","author":"Draper","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2019041117204379700_R4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jnci\/86.7.527","article-title":"Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.","volume":"86","author":"Fisher","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"2019041117204379700_R5"},{"key":"2019041117204379700_R6"},{"key":"2019041117204379700_R7"},{"key":"2019041117204379700_R8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000139284","article-title":"Antiestrogenic properties of raloxifene.","volume":"50","author":"Draper","year":"1995","journal-title":"Pharmacology"},{"key":"2019041117204379700_R9","first-page":"685","article-title":"Sonographic assessment of late proliferative phase endometrium during ovulation induction.","volume":"37","author":"Cohen","year":"1992","journal-title":"J Reprod Med"},{"key":"2019041117204379700_R10","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1210\/jcem-33-6-962","article-title":"Regulation of human gonadotropins. X. Episodic fluctuation of LH during the menstrual cycle.","volume":"33","author":"Midgley","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041117204379700_R11","author":"Abraham","year":"1977"},{"key":"2019041117204379700_R12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/00032717208062119","article-title":"Radioimmunoassay of plasma dehydroepiandrosterone sulfate.","volume":"5","author":"Buster","year":"1972","journal-title":"Anal Lett"},{"key":"2019041117204379700_R13","author":"Cotran","year":"1994"},{"key":"2019041117204379700_R14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0015-0282(16)30062-0","article-title":"Dating the endometrial biopsy.","volume":"1","author":"Noyes","year":"1950","journal-title":"Fertil Steril"},{"key":"2019041117204379700_R15","author":"Buckley","year":"1989"},{"key":"2019041117204379700_R16"},{"key":"2019041117204379700_R17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00006254-199601000-00021","article-title":"Clinical use of antiestrogens.","volume":"51","author":"Baker","year":"1996","journal-title":"Obstet Gynecol Surv"},{"key":"2019041117204379700_R18","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/jnci\/83.20.1488","article-title":"Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent.","volume":"83","author":"Jordan","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"2019041117204379700_R19","first-page":"377","article-title":"Comparison between tamoxifen and clomiphene for induction of ovulation.","volume":"61","author":"Messinis","year":"1982","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2019041117204379700_R20","first-page":"624","article-title":"Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer.","volume":"47","author":"Jordan","year":"1987","journal-title":"Cancer Res"},{"key":"2019041117204379700_R21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0015-0282(16)48069-6","article-title":"Clomiphene citrate: mechanisms and sites of action\u2013a hypothesis revisited.","volume":"42","year":"1984","journal-title":"Fertil Steril"},{"key":"2019041117204379700_R22","first-page":"187","article-title":"The effect of clomiphene citrate on follicular phase increase in endometrial thickness and uterine volume.","volume":"73","author":"Eden","year":"1989","journal-title":"Obstet Gynecol"},{"key":"2019041117204379700_R23","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0015-0282(16)55855-5","article-title":"Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles: effect of clomiphene citrate alone and with human menopausal gonadotropin.","volume":"59","author":"Dickey","year":"1993","journal-title":"Fertil Steril"},{"key":"2019041117204379700_R24","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1471-0528.1992.tb13708.x","article-title":"A prospective, randomised, cross-over study comparing the effects of clomiphene citrate and cyclofenil on endometrial morphology in the luteal phase of normal, fertile women.","volume":"99","author":"Li","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"key":"2019041117204379700_R25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01771666","article-title":"A pharmacological review of raloxifene.","volume":"14","author":"Bryant","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2019041117204379700_R26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0015-0282(16)56163-9","article-title":"The effect of clomiphene citrate and menopausal gonadotropins on cervical mucus in ovulatory cycles.","volume":"60","author":"Gelety","year":"1993","journal-title":"Fertil Steril"},{"key":"2019041117204379700_R27","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0015-0282(16)57597-9","article-title":"Clomiphene citrate reduces serum insulin-like growth factor I and increases sex hormone-binding globulin levels in women with polycystic ovarian syndrome.","volume":"63","author":"Butzow","year":"1995","journal-title":"Fertil Steril"},{"key":"2019041117204379700_R28","first-page":"5386","article-title":"Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients.","volume":"52","author":"Rose","year":"1992","journal-title":"Cancer Res"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/83\/1\/6\/9228420\/jcem0006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T01:51:34Z","timestamp":1555033894000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/83\/1\/6\/2865066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.83.1.4448","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1,1]]}}}